| Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens CM Rosenberger, BB Finlay Nature reviews Molecular cell biology 4 (5), 385-396, 2003 | 412 | 2003 |
| Interplay between antibacterial effectors: A macrophage antimicrobial peptide impairs intracellular Salmonella replication CM Rosenberger, RL Gallo, BB Finlay Proceedings of the National Academy of Sciences 101 (8), 2422-2427, 2004 | 294 | 2004 |
| Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression CM Rosenberger, MG Scott, MR Gold, REW Hancock, BB Finlay The Journal of immunology 164 (11), 5894-5904, 2000 | 279 | 2000 |
| Toll‐like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium‐induced colitis DL Gibson, C Ma, CM Rosenberger, KSB Bergstrom, Y Valdez, JT Huang, ... Cellular microbiology 10 (2), 388-403, 2008 | 226 | 2008 |
| Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics SA Ramsey, SL Klemm, DE Zak, KA Kennedy, V Thorsson, B Li, ... PLoS computational biology 4 (3), e1000021, 2008 | 225 | 2008 |
| SifA permits survival and replication of Salmonella typhimurium in murine macrophages JH Brumell, CM Rosenberger, GT Gotto, SL Marcus, BB Finlay Cellular microbiology 3 (2), 75-84, 2001 | 223 | 2001 |
| Microbial pathogenesis: lipid rafts as pathogen portals CM Rosenberger, JH Brumell, BB Finlay Current Biology 10 (22), R823-R825, 2000 | 201 | 2000 |
| Toll-Like Receptor 4 Contributes to Colitis Development but Not to Host Defense during Citrobacter rodentium Infection in Mice MA Khan, C Ma, LA Knodler, Y Valdez, CM Rosenberger, W Deng, ... Infection and immunity 74 (5), 2522-2536, 2006 | 194 | 2006 |
| SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans EK Allen, AG Randolph, T Bhangale, P Dogra, M Ohlson, CM Oshansky, ... Nature medicine 23 (8), 975-983, 2017 | 177 | 2017 |
| An α-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression MG Scott, CM Rosenberger, MR Gold, BB Finlay, REW Hancock The Journal of Immunology 165 (6), 3358-3365, 2000 | 141 | 2000 |
| miR-451 regulates dendritic cell cytokine responses to influenza infection CM Rosenberger, RL Podyminogin, G Navarro, GW Zhao, PS Askovich, ... The Journal of Immunology 189 (12), 5965-5975, 2012 | 139 | 2012 |
| A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm A Aderem, JN Adkins, C Ansong, J Galagan, S Kaiser, MJ Korth, GL Law, ... MBio 2 (1), 10.1128/mbio. 00325-10, 2011 | 130 | 2011 |
| Macrophages inhibit Salmonella typhimurium replication through MEK/ERK kinase and phagocyte NADPH oxidase activities CM Rosenberger, BB Finlay Journal of Biological Chemistry 277 (21), 18753-18762, 2002 | 118 | 2002 |
| Generation and protective ability of influenza virus–specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection, and experimental … S Jegaskanda, C Luke, HD Hickman, MY Sangster, WF Wieland-Alter, ... The Journal of infectious diseases 214 (6), 945-952, 2016 | 105 | 2016 |
| Flagellin-Dependent and -Independent Inflammatory Responses following Infection by Enteropathogenic Escherichia coli and Citrobacter rodentium MA Khan, S Bouzari, C Ma, CM Rosenberger, KSB Bergstrom, DL Gibson, ... Infection and immunity 76 (4), 1410-1422, 2008 | 96 | 2008 |
| ATF3 regulates MCMV infection in mice by modulating IFN-γ expression in natural killer cells CM Rosenberger, AE Clark, PM Treuting, CD Johnson, A Aderem Proceedings of the National Academy of Sciences 105 (7), 2544-2549, 2008 | 96 | 2008 |
| Phase 2 randomized, double-blind, placebo-controlled trial of RG7667, a combination monoclonal antibody, for prevention of cytomegalovirus infection in high-risk kidney … JH Ishida, A Patel, AK Mehta, P Gatault, JM McBride, T Burgess, ... Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 01794-16, 2017 | 93 | 2017 |
| miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis CM Rosenberger, RL Podyminogin, AH Diercks, PM Treuting, JJ Peschon, ... PLoS pathogens 13 (4), e1006305, 2017 | 89 | 2017 |
| Enteropathogenic Escherichia coli Infection Induces Expression of the Early Growth Response Factor by Activating Mitogen-Activated Protein Kinase Cascades in … M de Grado, CM Rosenberger, A Gauthier, BA Vallance, BB Finlay Infection and immunity 69 (10), 6217-6224, 2001 | 74 | 2001 |
| Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model JM McBride, JJ Lim, T Burgess, R Deng, MA Derby, M Maia, P Horn, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 01154-17, 2017 | 66 | 2017 |
